This Comment article provides a brief description of the work of the Affordable Medicines Facility for malaria to deal with the problem of unaffordability of antimalarial medicines, and the results of a pilot study in Uganda which reduced the price of artemisinin combination therapies, increased their availability and uptake, and reduced use of ineffective antimalarials such as chloroquine.
Talisuna, A.; Grewal, P.; Rwakimari, J.B.; Mukasa, S.; Jagoe, G.; Banerji, J. Cost is killing patients: subsidising effective antimalarials. Lancet (2009) 374 (9697) 1224-1226. [DOI: 10.1016/S0140-6736(09)61767-0]